Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc
Journal website https://www.cardiologyres.org

Original Article

Volume 4, Number 1, February 2013, pages 15-25


Using Novel Technology to Determine Mobility Among Hospitalized Heart Failure Patients: A Pilot Study

Figures

Figure 1.
Figure 1. Average daily hours spent lying, sitting, and standing or walking.
Figure 2.
Figure 2. Average daily time spent lying over hospital course.
Figure 3.
Figure 3. Average daily time spent standing or walking over hospital course.

Tables

Table 1. Study Procedure
 
Study Start - Day 1 (Baseline Measures)Study Days 2 - 4 (Check-in Visits)Study End - Day 5 or day of discharge
(Final Measures)
ADLs: Activities of Daily Living; NYHA: New York Heart Association; KPS: Karnofsky Performance Status Scale; SPPB: Short Physical Performance Battery.
Demographic: Age, gender, race, marital status;
Clinical: Vital Signs, symptoms, Ejection Fraction;
Functional: home exercise (self report), NYHA Class, Katz Index of ADLs, KPS, SPPB;
Mobility: Accelerometer monitors on ankle and thigh.
Skin: Check skin condition under monitors;
Mobility: Move accelerometer monitors to opposite ankle and thigh.
Clinical: Vital Signs, confirm receipt of PT in hospital;
Functional: NYHA Class;
Skin: Check skin condition under monitors;
Mobility: Remove accelerometer monitors.

 

Table 2. Sociodemographic and Clinical Characteristics (n = 32)
 
CharacteristicValue
ACEi: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; LVAD: left ventricular assistive device.
Age, mean years ± SD 58 ± 13
Male Gender, % (n) 78.1 (25)
Race/Ethnicity % (n)
  Caucasian/White 59.4 (19)
  African-American/Black 31.3 (10)
  Asian/Pacific Islander 9.4 (3)
History of smoking, % (n) 75.0 (24)
History of hypertension, % (n) 71.9 (23)
Creatinine on admission (g/dL), mean ± SD 1.9 ± 1.7
Etiology of Heart Failure, % (n)
  Ischemic 28.1 (9)
  Idiopathic 65.6 (21)
  Unknown/other 6.3 (2)
Ejection Fraction < 40%, % (n) 71.9 (23)
ACEi/ARB use - study end, % (n) 62.5 (20)
Beta blocker use - study end, % (n) 78.1 (25)
High-Risk Diagnoses for the Elderly Scale (study end), mean ± SD
  Low (0) = 9.5% chance dying in 1 year3.3 ± 1.7
  Intermediate (1 - 2) = 31% chance
  High risk (3 - 5) = 46% chance
  Very High Risk (> 6) = 74% chance
Length of hospital stay, mean in days ± SD 9.5 ± 9.9
Physical Therapy - in hospital, % (n) 34.4 (11)
LVAD received during study admission, % (n) 6.3 (2)
Discharged with Physical Therapy, Occupational Therapy, or Home Health, % (n) 40.6 (13)
Cardiac Events - 90 days post-discharge, % (n)
  Cardiac readmission 34.4 (11)
  Heart transplant 3.1 (1)
  Mortality 9.4 (3)

 

Table 3. Functional Status
 
CharacteristicValue
ADLs: activities of daily living; NYHA: New York Heart Association Class; SD: standard deviation.
Short Physical Performance Battery (mean ± SD) (n = 31) 6.4 ± 3.1
Accelerometer Mobility (mean minutes and hours ± SD, median minutes and hours) Mean Median
  Standing or Walking 59 ± 43 minutes 45.8 minutes
  Sitting 5.5 ± 3.0 hours 5.8 hours
  Lying 16.8 ± 3.2 hours 16.6 hours
Home exercise % (n) 62.5 (20)
Katz Index of Independence in ADLs (mean ± SD) 5.6 ± 1.1
NYHA Classification % (n) Study Start Study End
  Class I 6.3 (2) 15.6 (5)
  Class II 18.8 (6) 50.0 (16)
  Class III 56.3 (18) 31.3 (10)
  Class IV 18.8 (6) 3.1 (1)
Karnofsky Performance Status Scale
  Mean ± SD (range) 71.1 ± 9.0 (50 - 90)